Svetlana I Kayukova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Svetlana I Kayukova has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Andrey E. Donnikov
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
4 shared publications - Boris V. Nikonenko
Central Tuberculosis Research Institute
4 shared publications I. V. Bocharova
Central Research Institute of Tuberculosis, Moscow, Russia
3 shared publications- Marina F. Gubkina
Central Tuberculosis Research Institute; Pirogov Russian National Research Medical University, Russian Ministry of Health
3 shared publications - N. V. Yukhimenko
Central Tuberculosis Research Institute
3 shared publications - S. S. Sterlikova
Central Tuberculosis Research Institute
3 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (3) , 98-106
Prevention of Multidrug-Resistant Tuberculosis among Contacts (Literature Review)
This review summarizes the results of research on preventive treatment for multidrug-resistant tuberculosis (MDR-TB) contacts. A systematic literature search was conducted in the Google Scholar, PubMed and eLibrary databases to identify publications on the epidemiology and preventive treatment of MDR-TB contacts. The search covered the period from 2018 to 2025 using the following Medical Subject Headings (MeSH) keywords: “Tuberculosis, Multidrug-Resistant” / “Epidemiology”, “Transmission”, and “Prevention & Control”. Following the selection process, 41 publications were included in this literature review Results. The literature review demonstrated that the development and implementation of new, highly effective and safe antituberculosis drugs in preventive treatment regimens for MDR-TB contacts represents a promising approach to reducing the incidence of multidrug-resistant tuberculosis.
- 16 July 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (3) , 98-106
Open AccessPrevention of Multidrug-Resistant Tuberculosis among Contacts (Literature Review)
This review summarizes the results of research on preventive treatment for multidrug-resistant tuberculosis (MDR-TB) contacts. A systematic literature search was conducted in the Google Scholar, PubMed and eLibrary databases to identify publications on the epidemiology and preventive treatment of MDR-TB contacts. The search covered the period from 2018 to 2025 using the following Medical Subject Headings (MeSH) keywords: “Tuberculosis, Multidrug-Resistant” / “Epidemiology”, “Transmission”, and “Prevention & Control”. Following the selection process, 41 publications were included in this literature review Results. The literature review demonstrated that the development and implementation of new, highly effective and safe antituberculosis drugs in preventive treatment regimens for MDR-TB contacts represents a promising approach to reducing the incidence of multidrug-resistant tuberculosis.
- 1 June 2026
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 181 (2) , 223-227
Efficacy of Interferon-Gamma (Ingaron) against Experimental Tuberculosis in BALB/c Mice
- 1 June 2026
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 181 (2) , 223-227
Efficacy of Interferon-Gamma (Ingaron) against Experimental Tuberculosis in BALB/c Mice
- Open Access
- 22 March 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (1) , 8-16
The Impact of Chemotherapy for Drug-Resistant Respiratory Tuberculosis on the Composition of Fecal Microbiota in Children
The objective: to study the species and quantitative composition of fecal microbiota in children undergoing chemotherapy for drug-resistant respiratory tuberculosis. Subjects and Methods. The study included 17 children from 2 to 12 years old with respiratory tuberculosis who received treatment for drug-resistant respiratory tuberculosis from 2022 to 2024 at Central Tuberculosis Research Institute. Fecal microbiota was tested by real-time PCR using the ENTEROFLOR® Children reagent kit at the following time points: before the start of chemotherapy, after 2 and 4 months of chemotherapy. Results. The most pronounced disturbances in the intestinal microbiocenosis among representatives of normobiota were noted after 2 months of chemotherapy; by 4 months, those parameters did not deteriorate either in quantitative terms or frequency of deviations from reference values: for representatives of the phylum Actinomycetota (Actinobacteria) – in Bifidobacterium spp. and Coriobacteriia , for representatives of the phylum Bacteroidota (Bacteroidetes) – in Butyricimonas spp. , Parabacteroides spp., Prevotella spp. Changes in the composition of normobiota were associated with the elevated proportion of opportunistic microbiota by 2 months and persistence of these values by 4 months of chemotherapy. Representatives of pathogenic microbiota, which were not present before chemotherapy, appeared by 2 months of chemotherapy with the following frequency: Streptococcus agalactiae – in 35.3% of cases, Clostridioides difficile , with the toxigenic genes cdtA and cdtB – in 58.9%, and increasing to 71.5% by 4 months of chemotherapy. Conclusion. Treatment with chemotherapy regimens for drug-resistant tuberculosis has a statistically significant negative impact on intestinal microbiota in children: the proportion of normobiota decreases, the proportion of opportunistic microbiota increases, and pathogenic microbiota develops.
- 22 March 2026
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 104 (1) , 8-16
Open AccessThe Impact of Chemotherapy for Drug-Resistant Respiratory Tuberculosis on the Composition of Fecal Microbiota in Children
The objective: to study the species and quantitative composition of fecal microbiota in children undergoing chemotherapy for drug-resistant respiratory tuberculosis. Subjects and Methods. The study included 17 children from 2 to 12 years old with respiratory tuberculosis who received treatment for drug-resistant respiratory tuberculosis from 2022 to 2024 at Central Tuberculosis Research Institute. Fecal microbiota was tested by real-time PCR using the ENTEROFLOR® Children reagent kit at the following time points: before the start of chemotherapy, after 2 and 4 months of chemotherapy. Results. The most pronounced disturbances in the intestinal microbiocenosis among representatives of normobiota were noted after 2 months of chemotherapy; by 4 months, those parameters did not deteriorate either in quantitative terms or frequency of deviations from reference values: for representatives of the phylum Actinomycetota (Actinobacteria) – in Bifidobacterium spp. and Coriobacteriia , for representatives of the phylum Bacteroidota (Bacteroidetes) – in Butyricimonas spp. , Parabacteroides spp., Prevotella spp. Changes in the composition of normobiota were associated with the elevated proportion of opportunistic microbiota by 2 months and persistence of these values by 4 months of chemotherapy. Representatives of pathogenic microbiota, which were not present before chemotherapy, appeared by 2 months of chemotherapy with the following frequency: Streptococcus agalactiae – in 35.3% of cases, Clostridioides difficile , with the toxigenic genes cdtA and cdtB – in 58.9%, and increasing to 71.5% by 4 months of chemotherapy. Conclusion. Treatment with chemotherapy regimens for drug-resistant tuberculosis has a statistically significant negative impact on intestinal microbiota in children: the proportion of normobiota decreases, the proportion of opportunistic microbiota increases, and pathogenic microbiota develops.
- 1 January 2026
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 181 (2)
Efficacy of interferon-gamma (ingaron) in the treatment of BALB/c mice in a model of experimental tuberculosis
В экспериментальной модели туберкулёзной инфекции на инбредных мышах линии BALB/c исследовали терапевтическую активность препарата IFNγ (ингарон) отдельно и в сочетании с изониазидом. Показана наиболее высокая эффективность сочетания перорального приёма изониазида и подкожного введения IFNγ, подтверждённая микробиологическим и морфологическим исследованием лёгких и селезёнки, а также динамикой их массы.
- 1 January 2026
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 181 (2)
Efficacy of interferon-gamma (ingaron) in the treatment of BALB/c mice in a model of experimental tuberculosis
В экспериментальной модели туберкулёзной инфекции на инбредных мышах линии BALB/c исследовали терапевтическую активность препарата IFNγ (ингарон) отдельно и в сочетании с изониазидом. Показана наиболее высокая эффективность сочетания перорального приёма изониазида и подкожного введения IFNγ, подтверждённая микробиологическим и морфологическим исследованием лёгких и селезёнки, а также динамикой их массы.
- Open Access
- 5 November 2025
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 103 (5) , 73-83
The State of Vaginal Microbiota in Girls Aged 2-13 Years with Respiratory Tuberculosis during Chemotherapy
The objective : to study the species and quantitative composition of vaginal microbiota in the girls aged 2-13 years, ill with respiratory tuberculosis during chemotherapy. Subject and Methods : 80 girls aged 2-13 years were enrolled in the study: Group 1 (21 patients) included girls ill with respiratory tuberculosis at different stages of anti-tuberculosis therapy Group 2 (59 patients) included girls belonging to Health Groups 1 and 2, not registered in TB services. Vaginal microbiota was tested once using microscopy and real-time PCR (FEMOFLOR®16 reagent kit, DNA-Technology LLC, Russia). Results of the vaginal microbiota testing were assessed taking into account the Tanner stages for girls. Results . In girls from Group 1, vaginal dysbiosis was recorded in 90.5% of cases (with Tanner I – 100% of cases, Tanner II-III – 88.9%, Tanner IV – 85.7%) and was associated in 66.7% of cases with candidal vulvovaginitis (with Tanner I – 100% of cases, Tanner II-III – 55.6%, Tanner IV – 57.1%). Vaginal dysbiosis occurred with complaints in 19.0% of cases and clinical manifestations in 71.4% of cases. Specific features of the vaginal microbiota composition in girls of Group 1 were identified based on the frequency of detection and quantitative content of symbionts. The molecular genetic testing made it possible to increase the efficiency of diagnosing candidal vulvovaginitis to 66.7%, versus 28.6% in microscopic examination of scrapings from the mucous membrane of vulva and vaginal vestibule with a predominance of the species Candida glabrata (42.8%). Conclusion . The girls ill with tuberculosis and receiving anti-tuberculosis therapy suffer from significant changes in the species and quantitative composition of the vaginal microbiota.
- 5 November 2025
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 103 (5) , 73-83
Open AccessThe State of Vaginal Microbiota in Girls Aged 2-13 Years with Respiratory Tuberculosis during Chemotherapy
The objective : to study the species and quantitative composition of vaginal microbiota in the girls aged 2-13 years, ill with respiratory tuberculosis during chemotherapy. Subject and Methods : 80 girls aged 2-13 years were enrolled in the study: Group 1 (21 patients) included girls ill with respiratory tuberculosis at different stages of anti-tuberculosis therapy Group 2 (59 patients) included girls belonging to Health Groups 1 and 2, not registered in TB services. Vaginal microbiota was tested once using microscopy and real-time PCR (FEMOFLOR®16 reagent kit, DNA-Technology LLC, Russia). Results of the vaginal microbiota testing were assessed taking into account the Tanner stages for girls. Results . In girls from Group 1, vaginal dysbiosis was recorded in 90.5% of cases (with Tanner I – 100% of cases, Tanner II-III – 88.9%, Tanner IV – 85.7%) and was associated in 66.7% of cases with candidal vulvovaginitis (with Tanner I – 100% of cases, Tanner II-III – 55.6%, Tanner IV – 57.1%). Vaginal dysbiosis occurred with complaints in 19.0% of cases and clinical manifestations in 71.4% of cases. Specific features of the vaginal microbiota composition in girls of Group 1 were identified based on the frequency of detection and quantitative content of symbionts. The molecular genetic testing made it possible to increase the efficiency of diagnosing candidal vulvovaginitis to 66.7%, versus 28.6% in microscopic examination of scrapings from the mucous membrane of vulva and vaginal vestibule with a predominance of the species Candida glabrata (42.8%). Conclusion . The girls ill with tuberculosis and receiving anti-tuberculosis therapy suffer from significant changes in the species and quantitative composition of the vaginal microbiota.
- Open Access
- 18 July 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (3) , 191-200
The state of the microbiota of the respiratory tract in patients with tuberculosis of the respiratory system: literature review
Background. Tuberculosis is one of the leading infectious diseases that claim millions of lives every year. In the Russian Federation, over the past 10 years, there has been a steady decrease in the incidence and mortality from tuberculosis. The effectiveness of the treatment of respiratory tuberculosis depends on the genetics and immunology of the host, environmental factors, drug resistance of the pathogen (MDR/XDR), the presence of concomitant comorbid pathology (TB/HIV). However, the state of the microbiota continues to be poorly studied, but an important factor. The aim. To study the data of the world literature on the state of microbiocenosis of the respiratory tract in patients with tuberculosis of the respiratory system. Methods. The search and analysis of literary sources in international and domestic databases (Google Scholar, PubMed, eLibrary) for the period 2018–2023 were carried out. Discussion. To assess the microbiota of the respiratory tract, the 16s sequencing method of studying the species diversity of microorganisms is most successfully used. It has been proven that a violation of the microbiocenosis of the respiratory tract, namely the formation of dysbiosis against the background of persistent tuberculosis infection, can contribute to the development of bronchopulmonary complications. Currently, there is a wide variety of microorganisms inhabiting the respiratory tract of patients with tuberculosis of the respiratory system, while markers of pulmonary dysbiosis have not been established. Changes in the microbiota of the respiratory system depend on a number of factors: the presence/absence of bacterial release, sensitivity/resistance of the causative agent of tuberculosis to antibacterial drugs, chemotherapy regimen, etc. Conclusion. The composition of the microbiota of the respiratory tract in patients with tuberculosis of the respiratory system has not been studied enough. The available research is fragmented and not conceptual in nature. However, epidemiological realities (pandemics, the presence of tuberculosis–endemic countries and regions, the trend towards an increase in drug-resistant forms of tuberculosis, the high incidence of bronchopulmonary pathology of non-specific etiology in patients with pulmonary tuberculosis) necessitate representative studies on this topic.
- 18 July 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (3) , 191-200
Open AccessThe state of the microbiota of the respiratory tract in patients with tuberculosis of the respiratory system: literature review
Background. Tuberculosis is one of the leading infectious diseases that claim millions of lives every year. In the Russian Federation, over the past 10 years, there has been a steady decrease in the incidence and mortality from tuberculosis. The effectiveness of the treatment of respiratory tuberculosis depends on the genetics and immunology of the host, environmental factors, drug resistance of the pathogen (MDR/XDR), the presence of concomitant comorbid pathology (TB/HIV). However, the state of the microbiota continues to be poorly studied, but an important factor. The aim. To study the data of the world literature on the state of microbiocenosis of the respiratory tract in patients with tuberculosis of the respiratory system. Methods. The search and analysis of literary sources in international and domestic databases (Google Scholar, PubMed, eLibrary) for the period 2018–2023 were carried out. Discussion. To assess the microbiota of the respiratory tract, the 16s sequencing method of studying the species diversity of microorganisms is most successfully used. It has been proven that a violation of the microbiocenosis of the respiratory tract, namely the formation of dysbiosis against the background of persistent tuberculosis infection, can contribute to the development of bronchopulmonary complications. Currently, there is a wide variety of microorganisms inhabiting the respiratory tract of patients with tuberculosis of the respiratory system, while markers of pulmonary dysbiosis have not been established. Changes in the microbiota of the respiratory system depend on a number of factors: the presence/absence of bacterial release, sensitivity/resistance of the causative agent of tuberculosis to antibacterial drugs, chemotherapy regimen, etc. Conclusion. The composition of the microbiota of the respiratory tract in patients with tuberculosis of the respiratory system has not been studied enough. The available research is fragmented and not conceptual in nature. However, epidemiological realities (pandemics, the presence of tuberculosis–endemic countries and regions, the trend towards an increase in drug-resistant forms of tuberculosis, the high incidence of bronchopulmonary pathology of non-specific etiology in patients with pulmonary tuberculosis) necessitate representative studies on this topic.
- 30 June 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 6_2025, 140-148
Tuberculosis, fertility and pregnancy: the clinical and experimental aspects
- 30 June 2025
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 6_2025, 140-148
Tuberculosis, fertility and pregnancy: the clinical and experimental aspects
- 31 October 2024
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 10_2024, 11-18
Diagnosis and treatment of chronic endometritis in women with respiratory tuberculosis
- 31 October 2024
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 10_2024, 11-18
Diagnosis and treatment of chronic endometritis in women with respiratory tuberculosis
- 18 October 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 10,p. 143-149
Surgical heritage of academician Bogush L.K. and its influence on modern thoracic and phthisiatric surgery
The authors discuss the contribution of the outstanding scientist, surgeon, health care organizer and academician Lev K. Bogush in development of original surgeries that saved ten thousands of patients with respiratory diseases. The main periods of phthisiatric surgery are described (no antibacterial drugs and limited technical possibilities of surgical treatment, defining the place of surgery after emergence of specific effective drug treatment, introduction of resection options, drug-resistant forms of disease in population). In recent years, phthisiatric surgery is experiencing «second» birth, when it is increasingly used for destructive forms of disease. The authors emphasize the foresight of the scientist. He not only first performed many surgeries for pulmonary tuberculosis, but also created a whole direction in scientific and clinical development. The last one was later applied in other areas of thoracic surgery and oncology. Today, developments of academician Bogush L.K. are again in demand at the new stage of development of surgical science. This is especially clear in reconstructive tracheobronchial surgery, as well as surgical treatment of various complications after lung surgeries. Active surgical activity of Bogush L.K. fell on the period of two wars (the Finnish Company and the Great Patriotic War). He took active part in these conflicts and was the chief surgeon of several fronts for many years. Only a severe wound did not allow him to finish the war in Berlin. Rich surgical experience inspired further scientific and clinical researches in thoracic surgery.
- 18 October 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 10,p. 143-149
Surgical heritage of academician Bogush L.K. and its influence on modern thoracic and phthisiatric surgery
The authors discuss the contribution of the outstanding scientist, surgeon, health care organizer and academician Lev K. Bogush in development of original surgeries that saved ten thousands of patients with respiratory diseases. The main periods of phthisiatric surgery are described (no antibacterial drugs and limited technical possibilities of surgical treatment, defining the place of surgery after emergence of specific effective drug treatment, introduction of resection options, drug-resistant forms of disease in population). In recent years, phthisiatric surgery is experiencing «second» birth, when it is increasingly used for destructive forms of disease. The authors emphasize the foresight of the scientist. He not only first performed many surgeries for pulmonary tuberculosis, but also created a whole direction in scientific and clinical development. The last one was later applied in other areas of thoracic surgery and oncology. Today, developments of academician Bogush L.K. are again in demand at the new stage of development of surgical science. This is especially clear in reconstructive tracheobronchial surgery, as well as surgical treatment of various complications after lung surgeries. Active surgical activity of Bogush L.K. fell on the period of two wars (the Finnish Company and the Great Patriotic War). He took active part in these conflicts and was the chief surgeon of several fronts for many years. Only a severe wound did not allow him to finish the war in Berlin. Rich surgical experience inspired further scientific and clinical researches in thoracic surgery.
- 2 August 2024
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 177 (2) , 1-5
Impact of Experimental Tuberculosis on Fertility of Female BALB/c Mice
The study revealed no effects of pregnancy and childbirth on the course of tuberculosis in female BALB/c mice after aerosol infection with Mycobacterium tu
- 2 August 2024
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 177 (2) , 1-5
Impact of Experimental Tuberculosis on Fertility of Female BALB/c Mice
The study revealed no effects of pregnancy and childbirth on the course of tuberculosis in female BALB/c mice after aerosol infection with Mycobacterium tu